" class="no-js "lang="en-US"> EVERSANA - Medtech Alert
Friday, June 21, 2024
EVERSANA | Pharmtech Focus




EVERSANA™ combines the leading global life science services into an integrated and intelligent commercialization platform. With services rooted in the patient experience and spanning global pricing, market access, marketing, patient support, channel distribution, and consulting, we create value for patients, prescribers and payers at all stages of the product lifecycle.

To learn more about our work to help clients – ranging from innovative start-ups to established pharmaceutical companies – advance life science services for a healthier world, visit eversana.com.

Related Story

EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis

March 24 2023

EVERSANA, a leading provider of commercialization services to the life science industry, today announced a […]

Xspray Pharma Partners with EVERSANA for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

February 23 2023

Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of […]

Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.

September 28 2022

Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and […]

EVERSANA Unveils Global Price and Market Access Solution NAVLIN by EVERSANA

March 18 2022

EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today […]

EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access, Channel and Patient Services

October 18 2021

EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced […]

EVERSANA ™ Expands Medical Information and Integrated Compliance Services Across Europe

June 21 2021

EVERSANA ™, the pioneer of next generation commercial services to the global life sciences industry, today […]

GENinCode Announces Major US Commercialisation Partnership with EVERSANA

June 14 2021

GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of […]